A new cancer treatment more potent than the best-selling cancer drug taxol is
working well in human trials. Epothilone, which comes from soil-dwelling
organisms called myxobacteria, stops cancer cells dividing as taxol does. When a
cell splits in two, elastic protein threads draw the chromosomes apart. But
epothilone binds to these “tubulins” and halts a tumour’s runaway cell division.
“Epothilone stops the chromosomes from being pulled apart,” says Herbie Newell
of the Newcastle University Cancer Research Unit.
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Are Neanderthals descendants of modern humans?
2
Neanderthal infants were enormous compared with modern humans
3
Collapse of key ocean current may release billions of tonnes of carbon
4
The biggest threat to Chernobyl is no longer radiation
5
From autism to migraines, birth order may have wide-reaching effects
6
A key solution to climate change isn't happening – and that's good
7
The man who crawls into the perilous heart of the Chernobyl reactor
8
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
9
Electric vehicle owners could earn thousands by supporting power grid
10
My life as a meteorologist in Chernobyl under Russian occupation
